New Partnership in Switzerland

Helsinki – July 8, 2021 – MVision AI, the cloud-based software service provider for radiotherapy treatment planning, today announces that the company has entered into a distribution partnership agreement with the Swiss provider of products and services for optimization of medical equipment, intellimed. Together, intellimed and MVision AI will work to offer, promote, sell, and support the MVision solutions. Intellimed provides advice and support for numerous medical centers, radiology services, private clinics, and public hospitals. 

“intellimed is committed to work with trustworthy companies that are pioneers in their field. This is why we are proud to be the swiss distributor for the MVision’s automatic segmentation solution in radiotherapy. Our partnership results from a common vision: artificial intelligence supporting doctors in their work by allowing them to gain speed and efficiency on a daily basis. Competence, trust and reactivity are what define the collaboration we have with Mvision and we are looking forward to our future projects,” said intellimeds co-founders, Rachel Unell and Jean-Pierre Van Den Bussche.

Mahmudul Hasan, CEO and co-founder of MVision AI, provided further explanation on the topic, “MVision’s guideline based AI segmentation is helping hospitals all over EU to standardize contouring process, and we are excited to bring this to our Swiss customers with this new partnership with intellimed.” 

Artificial intelligence in medicine is a growing field that is improving the lives of both hospitals and patients worldwide. MVision’s deep learning platform helps provide the best radiotherapy treatment possible with consistent quality contouring. MVision’s AI-powered Saas follows official consensus guidelines, delivers 3D organ models within minutes, and is GDPR compliant. The adept, intellimed offers products and services for a variety of customers who wish to invest in the optimization of their medical equipment and resources. Intellimed team is working closely with MVision AI’s expert team to provide reliable, high-quality and confidential services in the most timely manner to cancer clinics throughout Switzerland. 

For further information on intellimed:

Website: www.intellimed.ch 

Tel: +41 79 479 62 72

LinkedIn: https://www.linkedin.com/company/intellimed-switzerland/about/ 

To learn more about MVison AI: 

c/o Terkko Health Hub, Haartmaninkatu 4, 00290 Helsinki, Finland.

Tel: +358 (0) 40 5489 229

Email: info@ mvision.ai

For media inquiries:

Tel: +358 40 500 7915

Email: pr@mvision.ai

 

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

2.2.2024

World Cancer Day – Joining efforts for a better cancer care

World cancer day, celebrated on the 4th of February, was established more than 20 years ago. It represents an initiative of the Union for International Cancer Control (UICC) , the oldest and largest global membership organization dedicated to taking action on cancer. UICC has over 1150 member organizations in 172…

News

30.1.2024

How can AI-based auto-contouring improve the life of patients who need palliative radiation therapy?

Cancer is one of the leading causes of morbidity and death, worldwide. Approximately 18 million people are diagnosed with cancer each year and the number is expected to increase. Pain is experienced by two thirds of patients having advanced, metastatic or terminal disease (1). Other symptoms caused by compression on…

Articles

22.1.2024

MVision AI Announces Partnership with Medron Medical Systems (Canada)

HELSINKI, Finland - January 22, 2024 MVision AI, a premier software service provider of GBS™ (Guideline-Based Segmentation) solution for same-day radiotherapy treatment planning, proudly announces a new distribution partnership with Medron Medical Systems, a leading health equipment provider in Canada. This collaboration follows the receipt of Medical Device License (MDL)…

Press Releases